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Support vector machineFor cancer classiﬁcation problems based on gene expression, the data usually has only a few dozen sizes
but has thousands to tens of thousands of genes which could contain a large number of irrelevant genes.
A robust feature selection algorithm is required to remove irrelevant genes and choose the informative
ones. Support vector data description (SVDD) has been applied to gene selection for many years. How-
ever, SVDD cannot address the problems with multiple classes since it only considers the target class.
In addition, it is time-consuming when applying SVDD to gene selection. This paper proposes a novel fast
feature selection method based on multiple SVDD and applies it to multi-class microarray data. A recur-
sive feature elimination (RFE) scheme is introduced to iteratively remove irrelevant features, so the pro-
posed method is called multiple SVDD-RFE (MSVDD-RFE). To make full use of all classes for a given task,
MSVDD-RFE independently selects a relevant gene subset for each class. The ﬁnal selected gene subset is
the union of these relevant gene subsets. The effectiveness and accuracy of MSVDD-RFE are validated by
experiments on ﬁve publicly available microarray datasets. Our proposed method is faster and more
effective than other methods.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Cancer classiﬁcation is one of the conventional problems in
microarray gene expression data [1–7]and includes tumor detec-
tion and prediction of some rare diseases [8–11]. Many methods
have been applied to cancer classiﬁcation, such as naive Bayes clas-
siﬁer (NBC) [12], partial least squares discriminant analysis
(PLSDA) [13], support vector Machines (SVMs) [14,15], and k near-
est neighbor (kNN) [16].
The accuracy of cancer classiﬁcation largely depends on the bio-
logical relevance of genes [17]. Thus, gene selection can be viewed
as a key stage for cancer classiﬁcation based on microarray data
and feature selection algorithms have been rapidly developed in
the past few decades. For the gene expression data, the expression
level of some genes is highly correlated, which plays an important
role in biological evolution. When these genes are located on the
same biological path, this correlation is more pronounced [18]. In
this case, traditional feature selection methods ignore the relation-
ships between genes, and choose only a few from these highly
related genes. The irrelevant genes not only result in lower classi-ﬁcation performance, but also add extra difﬁculties in ﬁnding
informative genes [19,20].
As a general learner, SVM could be applied to the problems of
classiﬁcation [21], regression [22], and feature extraction [23].
Here, we focus on feature selection. Considering whether the
evaluation criterion involves classiﬁcation models, we can divide
SVM-based feature selection methods into three groups: wrapper
feature selection based on SVM, embedded feature selection based
on SVM, and hybrid feature selection of ﬁlter and wrapper based
on SVM.
Weston et al. proposed the wrapper feature selection algorithm
based on SVM, which ﬁnds useful features by minimizing bounds
on the leave-one-out error using gradient descent [24]. Guyon
et al. proposed a SVM-RFE (recursive feature elimination) feature
selection algorithm, which is the most representative algorithm
[23]. Duan et al. presented a gene selection method similar to
SVM-RFE, called MSVM-RFE. At each step, MSVM-RFE trains multi-
ple linear SVMs on subsamples of training data and computes the
feature ranking scores from statistical analysis of the weight vec-
tors [25]. However, MSVM-RFE is computationally more expensive
than SVM-RFE. Embedded feature selection algorithms based on
SVM are similar to other embedded methods. Li et al. proposed
an embedded feature selection algorithm [26] that can adaptively
identify important features through introducing data driven
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selection. However, this method requires adjusting more parame-
ters, and its performance largely depends on those parameters.
How to design the objective function based on the standard SVM
is the key and difﬁcult issue of this type of algorithm. Lee and
Leu proposed a hybrid feature selection algorithm based on SVM
for microarray data analysis [27]. Speciﬁcally, this method uses
the genetic algorithm to generate a number of subsets of genes,
the chi square test to select a proper number of the top-ranked
genes for data analysis, and SVM to verify the efﬁciency of the
selected genes.
Among the methods mentioned above, SVM-RFE has attracted
considerable attention for its simplicity and intuition. However,
since SVM-RFE can only be applied to binary classiﬁcation prob-
lems, Jeong et al. proposed feature selection algorithms based on
support vector data description (SVDD) for one-class classiﬁcation
problems [28]. SVDD can describe a target data distribution, also
called one-class SVM [29–31]. Two feature selection algorithms
based on SVDD were presented in [28], or SVDD-radius-RFE and
SVDD-dual-objective-RFE. SVDD-radius-RFE minimizes the bound-
ary of target samples measured by its radius squared [28]. SVDD-
dual-objective-RFE maximizes a dual-objective function of SVDD
to provide a compact description boundary. However, it is very
time-consuming to apply both SVDD-based methods to gene
selection.
SVDD-based feature selection methods were proposed for one-
class classiﬁcation problems, and they cannot be applied to multi-
class problems. Although SVM-RFE can be extended to multi-class
classiﬁcation problems by using the strategies of one-against-all
[32], one-against-one [33], decision tree [34], and so on, its training
speed is not optimistic.
To solve multi-class classiﬁcation problems and reduce the time
complexity of both SVM-RFE and the SVDD-based feature selection
methods, we propose a multiple SVDD-RFE (MSVDD-RFE) method.
Speciﬁcally, we ﬁrst learn multiple feature selection models via
multiple SVDD models, where each class has a corresponding
model. For each model, we remove features according to the direc-
tion energy of its center vector. If the energy in some direction is
small, the feature corresponding to this direction is eliminated.
In doing so, multiple feature subsets are obtained by multiple
models. Then, we combine these subsets into the selected feature
subset. The concept of MSVDD-RFE can be generalized to SVDD-
radius-RFE and SVDD-dual-objective-RFE when handling multi-
class classiﬁcation problems. We validate that MSVDD-RFE
provides more precise classiﬁcation performance and less time
consumption, by experiments on ﬁve public microarray datasets.
Section 2 introduces SVDD and two SVDD-based feature selec-
tion algorithms, and proposes multiple SVDD for feature selection.
Simulation experiments are presented in Section 3 and our conclu-
sions are presented in Section 4.
2. Methods
We introduce SVDD and the two feature selection methods
based on SVDD, and propose the multiple SVDD-based feature
selection method.
2.1. Support vector data description
SVDD is a one-class classiﬁer [29–31]. Compared with SVM,
SVDD only allows learning from one-class data. SVDD can be
implemented using hyperplane or hypersphere methods. The for-
mer takes the origin as an abnormal point and makes an optimal
hyperplane away from it as far as possible [35], and the latter con-
structs a hypersphere to contain as many targets as possible
[29,31]. For SVDD, we only need one-class data or target samplesto construct the learning model expressed by a hypersphere. If a
point falls within the hypersphere, it belongs to the target sample
set; otherwise, it would be an abnormal point, or outlier.
Given a set of target samples fxigni¼1, where xi 2 RD denotes the
target sample, D is the dimensionality of the target sample, and n is
the number of target sample, we try to ﬁnd a hypersphere with
minimum volume containing all (or most of) the data. To achieve
this, we need to know two parameters, the hypersphere center,
a, and radius, R. The initial form of optimization problem is
min
R;a;ni
R2 þ C
Xn
i¼1
ni
s:t: xi  ak k2 6 R2 þ ni; ni P 0; i ¼ 1; . . . ;n;
ð1Þ
where ni is a slack variable, and C > 0 is the penalty factor which
allows trade-off between the volume of hypersphere and the num-
ber of target objects rejected.
Using the Lagrange multiplier technique, we obtain the dual
programming form of (1),
min
a
Xn
i¼1
Xn
j¼1
aiajxTi xj 
Xn
i¼1
aixTi xi
s:t:
Xn
i¼1
ai ¼ 1 ;0 6 ai 6 C; i ¼ 1; . . . ;n;
ð2Þ
where ai is the Lagrange multiplier. The hypersphere center, a, and
radius, R, can be expressed by Lagrange multipliers,
a ¼
Xn
i¼1
aixi; ð3Þ
and
R2 xsvð Þ ¼ xsv  ak k2 ¼ xTsvxsv  2
Xn
i¼1
aixTsvxi þ
Xn
i¼1
Xn
j¼1
aiajxTi xj; ð4Þ
where xsv is a support vector with its corresponding Lagrange mul-
tiplier 0 < asv < C.
2.2. SVDD-based feature selection methods
Two SVDD-based feature selection methods were proposed in
[28] and are described brieﬂy here. There are two cases, consider-
ing either a few outliers and targets, or only considering targets.
We will only discuss the latter.
2.2.1. SVDD-radius-RFE
The performance of SVDD strongly depends upon how com-
pactly the constructed hypersphere describes the target samples,
while discriminating outliers [28]. The size of hypersphere can be
characterized by its radius. The criterion for feature selection in
SVDD-radius-RFE is related to the hypersphere radius. The term
R2 xsvð Þ in (4) is the radius square based on xsv . Let SV be the sup-
port vector set. Then the average radius square, Jr , is deﬁned as
Jr ¼
X
xsv2SV
R2 xsvð Þ
SVj j ; ð5Þ
which may be rewritten as
Jr ¼
1
SVj j
X
xsv2SV
xTsvxsv  2
Xn
i¼1
aixTsvxi þ
Xn
i¼1
Xn
j¼1
aiajxTi xj
 !
: ð6Þ
Let Jr pð Þ be the size of hypersphere excluding feature p. The
worst feature is the one with the largest Jr pð Þ. That is, feature p
has little effect on the size of the hypersphere. The worst feature
[28] is the one with the smallest value of Jr  Jr pð Þð Þ. Thus, the cri-
terion function of SVDD-radius-RFE is
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p¼1;...;D
Jr  Jr pð Þð Þ; ð7Þ
which implies that feature p should be removed from the feature
set.
2.2.2. SVDD-dual-objective-RFE
Let Jd and Jd pð Þ be the value of the objective function in the
dual programming of SVDD and the recalculated value of the objec-
tive function without feature p, respectively. Thus, we have
Jd ¼
Xn
i¼1
aixTi xi 
Xn
i¼1
Xn
j¼1
aiajxTi xj; ð8Þ
and
Jd pð Þ ¼
Xn
i¼1
a pð Þix pð ÞTi x pð Þi

Xn
i¼1
Xn
j¼1
a pð Þia pð Þjx pð ÞTi x pð Þj; ð9Þ
where ðpÞ denotes that feature p has been removed. The effect of
removing redundant features is calculated by Jd  Jd pð Þð Þ.
Similarly, the criterion function of SVDD-dual-objective-RFE can
be expressed as
p ¼ argmax
p¼1;...;D
Jd  Jd pð Þð Þ; ð10Þ
which also implies that feature p should be removed from the fea-
ture set.
2.3. The proposed method
We propose a novel SVDD-based feature selection method for
multi-class classiﬁcation tasks. Distinct from SVDD-radius-RFE
and SVDD-dual-objective- RFE, the center point is used to select
features. Let the center point be a ¼ a1; a2; . . . ; aD½ T , where aij j
could represent the average magnitude in the i-th direction on
all target samples. Let a2i denote the energy of the i-th direction.
Larger a2i implies wider distribution of target data in the i-th direc-
tion. Conversely, if a2i is small, then the data must be compact in
the i-th direction. Our goal is to contain as many target points as
possible. Compact data would produce a small hypersphere radius,
which could not contain most target data. Thus, features in com-
pact distribution direction(s) should be removed, and those in dis-
persed distribution direction(s) should be retained.
Suppose we have a set of training samples X ¼ fxi; yigni¼1, where
xi 2 RD;D is the dimensionality of samples, yi 2 f1;2; . . . ; cg is the
class label of xi; c is the number of classes, and n is the number
of samples. Only one class is used to train an SVDD model without
considering the other classes. We train an SVDD model for each
class to make full use of the training samples. Fig. 1 gives the
framework of MSVDD-RFE. We ﬁrst divide the set X into c subsets
according to class labels, where Xj denotes the subset containing
samples belonging to the j-th class. Then we train an SVDD model
for the j-th class, producing feature subset Fj. Finally, these feature
subsets are combined to form the index subset, F.Fig. 1. Framework of MSVDD-RFE.Similar to SVM-RFE, we remove one feature from the feature set
in each iteration. Using the subset Xj, we train an SVDD model and
obtain the center vector, aj, for the j-th class. Since aji
 2
represents
the importance of the i-th feature in the j-th class, we can eliminate
unimportant features based on the energy. We remove the feature
with smallest aji
 2
from the current feature set and update the
subset Xj which now contains less features. We repeat the proce-
dure until we obtain sufﬁcient features. We combine the c index
subsets, Fj; j ¼ 1; . . . ; c, to generate the index subset, F, which could
contain more discriminating features than any individual Fj, due to
all categories being considered. The detail algorithm is given in
Algorithm 1.
Feature subsets in Algorithm 1 are the index sets of selected
features, i.e., these features are retained. We focus on the feature
selection and obtain a new dataset with less features. Any suitable
classiﬁer, such as SVM, kNN, or neural network could be used to
build a classiﬁcation model on the resultant dataset.
Algorithm 1. MSVDD-RFE
Input: Training samples xi; yif gni¼1, and the dimensionality of
the subspace d.
Output: Index subset of selected features F.
1 For j ¼ 1;2; . . . ; c
2. For the j-th training set, Xj ¼ xi; yi ¼ jf g, initialize the
index set of selected features, Fj ¼ 1;2; . . . ;Df g, and let
m ¼ D.
3. Solve the dual programming (2), and obtain the center of
the j-th hypersphere, aj ¼ aj1; aj2; . . . ; ajm
h iT
2 Rm.
4. Compute the energy of all feature directions
ðajiÞ
2
; i ¼ 1; . . . ;m.
5. Find the feature with smallest energyp ¼ argmini¼1;...;mðajiÞ
2
.
6. Let m ¼ m 1, remove feature p, update the training set,
Xj ¼ xi; yi ¼ jf g;xi 2 Rm, and the index subset of selected
features, Fj ¼ Fj n p.
7. If m ¼ d, then save Fj and goto 1; otherwise goto 3.
8 End
9. Let F ¼ F1 [ F2 [    [ Fc , and output it.2.4. Extension of other methods and analysis of computational
complexity
SVM-RFE could be extended to multi-class classiﬁcation prob-
lems using the one-against-one, one-against-all, and/or decision
tree methods. For these methods, we need multiple SVMs. For the
one-against-all method, c SVM models would be required, while
the one-against-one and decision tree methods, would require
ðcðc  1Þ=2Þ and ð2c  1Þ models, respectively. For each model,
we can select a feature subset. However, for all these methods the
training data must be repeatedly used, which results in irrelevant
features. Since the one-against-onemethod is the faster of the three
[33], we used that as a comparator in our experiments. For simplic-
ity, SVM-RFE with one-against-one is denoted by M-SVM-RFE.
The SVDD-radius-RFE and the SVDD-dual-objective-RFE meth-
ods can also be extended to multi-class tasks using our concept.
We can build multiple SVDD for both methods, and we call them
MSVDD-radius-RFE and MSVDD-dual-objective-RFE, respectively.
The selection criteria are unchanged. MSVDD-radius-RFE removes
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objective-RFE removes the feature with the largest Jd  Jd pð Þð Þ.
These two extended methods are compared with our proposed
method.
We analyze the computational complexity for these multi-task
methods. Without loss of generality, let n0 ¼ n=c where n0 is the
number of samples in each class. Since both SVM and SVDD are
quadratic programs, their complexity is related to the number of
variables. Let the computational complexity of single SVM be
ComQ ð2n0Þ  Oð8n03Þ, and that of single SVDD be
ComQ ðn0Þ  Oðn03Þ. When using SVM-RFE to select features, the
computational complexity of one model is OððDþ 8n03ÞðD dÞÞ,
where d is the dimensionality of the subspace. In MSVDD-RFE, a
model has computational complexity OððDþ n03ÞðD dÞÞ. When
applying MSVDD-radius-RFE and MSVDD-dual-objective-RFE, the
computational complexity of a model is Oððn02Dþ n03ÞðD dÞÞ. The
total computational complexity is shown in Table 1. MSVDD-RFE
can make full use of training data and simultaneously realize
less computation load among SVDD-like methods. Compared to
M-SVM-RFE, MSVDD-RFE would have a smaller computational
complexity when the number of classes c is larger than three or
the iteration ðD dÞ is large enough.
3. Results and discussion
3.1. Datasets and experimental setting
Five publicly available gene microarray datasets were used to
validate the performance of our proposed method, and summa-
rized in Table 2. The ﬁrst two datasets (Leukemia and colon Tumor)
are two-class datasets, while the other three datasets (Leukemia3,
Novartis, and Lung Cancer) are multi-class.
In these data sets, all genes are expressed as numerical values at
different measurement levels. Since the value aji
 2
is related to
the value of genes, we normalize each gene on the interval ½0;1,
so that all genes can be measured on the same scale.
We also consider other feature selection methods. For two-class
datasets, six methods were compared: SVM-RFE, SVDD-radius-RFE,
SVDD-dual-objective-RFE, MSVDD-radius-RFE, MSVDD-dual-
objective -RFE, and MSVDD-RFE. Note that, for SVDD-radius-RFE
and SVDD-dual-objective-RFE, only one-class samples are sup-
ported. We chose the class with the largest number of samples,
or randomly chose the target class when each class had the same
number of samples. For multi-class datasets we used only four
methods: M-SVM-RFE, MSVDD-radius-RFE, MSVDD-dual-objec-
tive-RFE, and MSVDD-RFE. In these methods, the parameter C has
a vital inﬂuence on experimental result. Therefore, we use 5-fold
cross validation to select C to achieve the best results. In the
SVDD-like methods, the parameter C takes ﬁve linearly and equally
spaced values in the interval ½1=n;1, where n is the number of
training samples. For SVM, C takes values in the set
f0:1;1;10;100;1000g.
We use recalls to evaluate the performance of the methods. The
recall of the j-th class is
Recallj ¼ TPjTPj þ FNj ; ð11ÞTable 1
Comparison of computational complexity.
Method Computational complexity
M-SVM-RFE cðc  1Þ=2ðOððDþ 8n03ÞðD dÞÞÞ
MSVDD-radius-RFE cðOððn02Dþ n03ÞðD dÞÞÞ
MSVDD-dual-objective-RFE cðOððn02Dþ n03ÞðD dÞÞ
MSVDD-RFE cðOððDþ n03ÞðD dÞÞÞwhere TPj is the number of correctly classiﬁed samples, and FNj is
the number of incorrectly classiﬁed samples in the j-th class. We
coded the problems in Matlab R2013a, and conducted the experi-
ments using a Pentium PC with 2.8 GHz processor and 2 GB main
memory.
3.2. Leukemia dataset
There are two types of leukemia: Acute Lymphoblastic Leuke-
mia (ALL) and Acute Myeloid Leukemia (AML). We split the into
two subsets: a training set used to select genes and adjust the
parameters of classiﬁers, and a test set used to estimate the perfor-
mance of the obtained system. All samples had 7129 features, cor-
responding to some normalized gene expression values extracted
from microarray images. We took ALL as the target samples and
AML as negative samples. This dataset can be found in [36].
MSVDD-RFE, our proposed method, was compared with SVM-
RFE, SVDD-radius-RFE, SVDD-dual-objective-RFE, MSVDD-radius-
RFE, MSVDD-dual-objective-RFE, and no feature selection. For
SVM-RFE, SVDD-radius-RFE and SVDD-dual-objective-RFE meth-
ods, we found 200 useful features. For MSVDD-RFE, MSVDD-
radius-RFE and MSVDD-dual-objective-RFE methods, we used a
separate SVDD model to select 100 features and combined these.
Hence, we found at most 200 features for these methods.
As discussed above, after obtaining the feature subset, we can
use any classiﬁer to classify the reduced data. Here, we compare
k nearest neighbor and SVM.
3.2.1. kNN classiﬁer
kNN is a popular conventional classiﬁer due to its simplicity and
efﬁciency. kNN ﬁnds the k nearest points in the training set for a
new test point, and assigns it to the most common class among
those neighbors, Since k inﬂuences the classiﬁcation accuracy, a
3-fold cross validation for k was performed on the training set.
Considering the average recall of all methods, we set k ¼ 5 in the
following experiments.
Table 3 shows the classiﬁcation results and running time of
these methods.
MSVDD-RFE provides the best average recall, which means that
the selected features are more discriminative. The recall rate of
AML using MSVDD-RFE is 57% greater than that of MSVDD-dual-
objective-RFE, and approximately 6 times that obtained by
SVDD-radius-RFE. The average recall rate is also higher (approxi-
mately 25%-35%) than the suboptimal result. Comparing computa-
tional time, MSVDD-RFE takes signiﬁcantly less time than all other
feature selection methods.
MSVDD-RFE is outstanding among the methods listed here. The
experimental results verify the feasibility and effectiveness of our
method in feature selection.
3.2.2. SVM classiﬁer
SVM is a state of the art classiﬁcation system, and has been
widely used for classiﬁcation and regression problems. SVM tries
to ﬁnd an optimal hyperplane with maximal margin.
In the SVM classiﬁer, linear and RBF kernels are used. The RBF
kernel requires a kernel parameter, and so the regularization
parameter C and kernel parameter were selected by 3-fold cross
validation on the training set (Table 4). The advantage of
MSVDD-RFE, our proposed method, compared with other methods
is clear. The SVM classiﬁer may more suitable for obtaining higher
average recall across all the methods, but note that the average
recall of MSVDD-RFE is higher with kNN (Table 3). However, the
selection of hyperparameters in SVM is a common and difﬁcult
problem. Thus, we chose kNN to classify the selected features for
its simplicity and efﬁciency.
Table 2
Description of ﬁve datasets.
Dataset Class Gene Training set Test set
Leukemia 2(ALL/AML) 7129 38(27/11) 34(20/14)
Colon Tumor 2(Tumor/Normal) 2000 31(20/11) 31(20/11)
Leukemia3 3(B-ALL/T-ALL/AML) 999 20(10/4/6) 18(9/4/5)
Novartis 4(Breast/Prostate/Lung/Colon) 1000 52(13/13/14/12) 51(13/13/14/11)
Lung Cancer 5(ADEN/SQUA/COID/SCLC/NORMAL) 12,600 103(70/11/10/3/9) 100(69/10/10/3/8)
Table 3
Comparison of different methods on the Leukemia dataset with kNN. The bold values denote the best average recall among those obtained by the compared methods.
Feature selection method None SVM-RFE SVDD-radius-RFE SVDD-dual-objective-RFE MSVDD-radius-RFE MSVDD-dual-objective-RFE MSVDD-RFE
C1 – 100 1 0.28 1 0.28 0.037
C2 – – – – 1 0.09 0.32
Recall of ALL (%) 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Recall of AML (%) 29.00 35.71 14.29 21.43 21.43 35.70 92.86
Average recall (%) 64.50 67.86 57.14 60.71 60.71 67.86 96.43
Running time (s) – 629.96 10359.75 9522.17 21,671 29,780 335.63
Note: ‘‘none’’ means the method without feature extraction, ‘‘running time’’ means the time consumed on feature selection, and the symbol ‘‘–’’ denotes no result in an entry.
Table 4
Comparison of different methods on the the Leukemia dataset with SVM. The bold values denote the best average recall among those obtained by the compared methods.
Method Linear kernel RBF kernel
Recall of ALL (%) Recall of AML (%) Average recall (%) Recall of ALL (%) Recall of AML (%) Average recall (%)
None 100.00 57.14 78.57 100.00 28.57 64.29
SVM-RFE 100.00 57.14 78.57 100.00 64.29 82.14
SVDD-radius-RFE 100.00 50.00 75.00 100.00 35.71 67.86
SVDD-dual-objective-RFE 100.00 35.71 67.86 100.00 28.57 64.29
MSVDD-radius-RFE 100.00 35.71 67.86 100.00 42.86 71.43
MSVDD-dual-objective-RFE 95.00 71.43 83.21 100.00 21.43 60.71
MSVDD-RFE 95.00 92.86 93.93 95.00 92.86 93.93
Note: ‘‘none’’ means the method without feature extraction.
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We compared the selected features obtained by these methods
on the Leukemia dataset. The criterion function values of different
methods (Fig. 2, criterion values are set to zero when they are not
selected) were used to measure the signiﬁcance of selected
features.
In [37] showed the 50 genes most highly correlated with the
ALL-AML class distinction. We compared the feature selection
methods with that list, to measure the accuracy of selection of
important genes. Table 5 shows the percentage of important genes
among those selected by these methods. MSVDD-RFE (11.50%) and
SVM-RFE (11.22%) are very close, but the other SVDD-based meth-
ods select at most one important gene. MSVDD-RFE can not only
quickly select genes, but also discriminate the AML and ALL classes
well. Table 6 gives the index, gene identity (Gene ID) and deﬁnition
of four genes which are simultaneously selected by two SVDD
models in our method.
3.3. Colon tumor dataset
Similar to the Leukemia dataset, the colon Tumor dataset also
has two classes, or tumor and normal. Among them, 40 tumor
biopsies are from tumors and 22 normal biopsies are from healthy
parts of the colons of the same patients. Two thousand out of
around 6500 genes were selected based on the conﬁdence in the
measured expression levels. We take the 40 tumor biopsies as
the target samples and 22 normal biopsies as negative samples
in colon Tumor. Since there is no deﬁned training and test set,
we randomly select training and test samples. In addition, our ﬁnal
result is the average on the 10 runs so as to avoid randomness. This
dataset can be found in [38].Experimental setting is the same as that in Section 3.2. The
average results are shown in Table 7. On the colon Tumor dataset,
MSVDD-RFE is inferior to MSVDD-dual-objective-RFE which
achieves the best recall. MSVDD-dual-objective-RFE is an exten-
sion method using the idea of our multiple SVDDmodels. However,
MSVDD-RFE is much faster than MSVDD-dual-objective-RFE. In
addition, MSVDD-RFE is inferior to SVM-RFE which has the least
time cost. But the selected features by SVM-RFE are not so useful
for classiﬁcation. In summary, the method proposed here still has
certain advantages. Note that the extend versions of SVDD-
radius-RFE and SVDD-dual-objective-RFE get better recall rates
than the original versions. It is reasonable that the two extend ver-
sions have higher time costs since they need to address multiple
hyperspheres. In addition, Table 8 also gives the index, Gene ID
and deﬁnition of six genes which are simultaneously selected by
two SVDD models in our method.
MSVDD-RFE is inferior to MSVDD-dual-objective-RFE which
achieves the best result at the cost of speed. This allows us to make
more meaningful comparisons between the two methods. We
respectively take the reduced dimension 50, 100, 400 and 800.
The other experimental setting are not changed. From Fig. 3, we
have the similar conclusion as those from Table 7. Although
MSVDD-RFE has a worse classiﬁcation performance than MSVDD-
dual-objective-RFE, the running time of MSVDD-RFE is much less
than that of MSVDD-dual-objective-RFE.
3.4. Multi-class datasets
The Leukemia3, Novartis, and Lung Cancer datasets are multi-
class datasets. The ﬁrst two datasets can be downloaded from
http://www.broadinstitute.org/cgi-bin/cancer/datasets.cgi, while
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Fig. 2. Values of ranking criteria obtained by different methods.
Table 5
Important selected genes proportion for selected genes.
Feature selection method Number of imported genes in 50 Important selected genes proportion for selected genes (%)
SVM-RFE 23 11.50
SVDD-radius-RFE 0 0
SVDD-dual-objective-RFE 1 0.5
MSVDD-radius-RFE 0 0
MSVDD-dual-objective-RFE 1 0.5
MSVDD-RFE 22 11.22
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datasets/krbd/LungCancer/LungCancer-Harvard1.html. The Leuke-
mia3 dataset [37] is from the previous-generation Human Genome
HU6800 Affymetrix microarray, and consists of bone samples
obtained from acute leukemia patients at the time of diagnosis:11 acute myeloid leukemia (AML) samples, 8 T-lineage acute lym-
phoblastic leukemia (ALL) samples, and 19 B-lineage ALL samples.
The Novartis multi-tissue dataset [39] consists of four distinct can-
cer types: 26 breast, 26 prostate, 28 lung, and 23 colon samples,
and was processed on the Human Genome U95 Affymetrix
Table 6
Signiﬁcant genes selected by MSVDD-RFE for discrimination of AML and ALL samples in the Leukemia dataset.
Index Gene ID Description
1247 L08177 CMKBR7 Chemokine (C  C) receptor 7
4141 X13973 RNH Ribonuclease/angiogenin inhibitor
4196 X17042 PRG1 Proteoglycan 1, secretory granule
4377 X62654 rna1 ME491 gene extracted from Homo sapiens gene for Me491/CD63 antigen
Table 7
Comparison of different methods on the colon Tumor dataset.
Feature selection
method
None SVM-RFE SVDD-radius-
RFE
SVDD-dual-objective-
RFE
MSVDD-radius-
RFE
MSVDD-dual-objective-
RFE
MSVDD-
RFE
C1 – 100 0.76 0.29 1 1 0.05
C2 – – – – 1 0.32 0.55
Recall of tumor (%) 94.50 ± 0.05 93.00 ± 0.05 88.00 ± 0.11 92.00 ± 0.06 91.00 ± 0.06 91.50 ± 0.03 94.00 ± 0.04
Recall of normal (%) 36.36 ± 0.18 34.55 ± 0.13 37.27 ± 0.21 30.91 ± 0.11 35.45 ± 0.15 63.64 ± 0.20 51.82 ± 0.18
Average recall (%) 65.43 ± 0.09 63.77 ± 0.06 62.64 ± 0.12 61.45 ± 0.05 63.23 ± 0.07 77.57 ± 0.10 72.91 ± 0.09
Running time (s) – 323.16 3140.4 3162.9 5321.1 5044.6 388.12
Note: ‘‘none’’ means the method without feature extraction, ‘‘running time’’ means the time consumed on feature selection, and the symbol ‘‘–’’ denotes no result in an entry.
Table 8
Signiﬁcant genes selected by MSVDD-RFE for discrimination of tumor and normal samples in the colon Tumor dataset.
Index Gene ID Description
98 H13194 ADP-RIBOSYLATION FACTOR-LIKE PROTEIN 2 (Homo sapiens)
465 L33075 Homo sapiens ras GTPase-activating-like protein (IQGAP1) mRNA, complete cds
844 M63959 Human alpha-2-macroglobulin receptor-associated protein mRNA, complete cds
849 T54670 P13621 ATP SYNTHASE OLIGOMYCIN SENSITIVITY CONFERRAL PROTEIN PRECURSOR, MITOCHONDRIAL
1207 R39144 HEAT SHOCK FACTOR PROTEIN 2 (Homo sapiens)
1711 D21094 Human mRNA for motor protein, complete cds
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include 139 samples of lung adenocarcinomas (ADEN), 21 samples
of squamous cell lung carcinomas (SQUA), 20 samples of pulmon-
ary carcinoids (COID), 6 samples of small-cell lung carcinomas
(SCLC) and 17 normal lung samples (NORMAL). Each sample is
described by 12,600 genes for Lung Cancer.
For Leukemia3 and Novartis, we randomly selected training
samples, with the balance as test samples, and repeated this pro-
cess for 10 trials. We report the average results in Table 9 (for Leu-
kemia3) comparing M-SVM-RFE, MSVDD-dual-objective-RFE, and
MSVDD-radius-RFE, and MSVDD-RFE. We performed two-tailed
t-tests with signiﬁcant level 0.05 to determine signiﬁcant differ-
ences between our proposed method and the others, also shown
in Table 9. Our proposed method, MSVDD-RFE, is superior to theother methods for both recall rate and time cost. Furthermore,
MSVDD-RFE is signiﬁcantly superior to MSVDD-radius-RFE.
Table 10 summarizes the experimental results on the Novartis
dataset. MSVDD-RFE achieves the second best average recall, after
M-SVM-RFE. However, MSVDD-RFE choses useful features some-
what more quickly. The main reason is that Novartis is a four-class
dataset. Hence, M-SVM-RFE uses 6 binary SVM models, and
MSVDD-RFE employs four hyperspheres for four classes. MSVDD-
RFE is signiﬁcantly superior to MSVDD-dual-objective-RFE. Consid-
ering computational time, MSVDD-RFE is a good choice when the
number of classes in a dataset is large, which supports the analysis
of computational complexity.
Considering the high dimensionality of the Lung Cancer dataset,
only 5 trials are performed. All four methods discussed above were
Table 9
Comparison of different methods on the Leukemia3 dataset.
Feature selection method None M-SVM-RFE MSVDD-radius-RFE MSVDD-dual-objective-RFE MSVDD-RFE
C1 – 100 0.1 0.1 0.1
C2 – – 0.25 0.25 0.25
C3 – – 0.17 0.17 0.17
Recall of B-ALL (%) 98.89 ± 0.04 98.89 ± 0.04 98.89 ± 0.04 100.00 ± 0.00 98.89 ± 0.04
Recall of T-ALL (%) 95.00 ± 0.16 90.00 ± 0.17 87.50 ± 0.21 100.00 ± 0.00 100.00 ± 0.00
Recall of AML (%) 92.00 ± 0.14 78.00 ± 0.22 86.00 ± 0.19 80.00 ± 0.29 90.00 ± 0.11
Average recall (%) 95.30 ± 0.08 91.63 ± 0.08 88.13 ± 0.11 93.33 ± 0.08 96.30 ± 0.03
Running time (s) – 231.55 2458.4 1952.0 199.74
p value 0.647 0.0928 0.0251 0.278 –
Note: ‘‘none’’ means the method without feature extraction, ‘‘running time’’ means the time consumed on feature selection, and the symbol ‘‘–’’ denotes no result in an entry.
Table 10
Comparison of different methods on the Novartis dataset.
Feature selection method None M-SVM-RFE MSVDD-radius-RFE MSVDD-dual-objective-RFE MSVDD-RFE
C1 – 100 0.31 0.54 0.31
C2 – – 0.31 0.54 0.31
C3 – – 0.30 0.54 0.30
C4 – – 0.31 0.54 0.31
Recall of Breast (%) 96.92 ± 0.04 96.92 ± 0.04 96.15 ± 0.07 99.23 ± 0.02 95.38 ± 0.05
Recall of Prostate (%) 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00
Recall of Lung (%) 97.14 ± 0.05 99.29 ± 0.02 92.86 ± 0.07 87.86 ± 0.04 99.29 ± 0.02
Recall of Colon (%) 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00 100.00 ± 0.00
Average recall (%) 98.52 ± 0.02 99.05 ± 0.01 97.25 ± 0.02 96.77 ± 0.01 98.67 ± 0.02
Running time (s) – 875.06 2516.4 2176.1 249.70
p value 0.7341 0.4969 0.0975 0.0047 –
Note: ‘‘none’’ means the method without feature extraction, ‘‘running time’’ means the time consumed on feature selection, and the symbol ‘‘–’’ denotes no result in an entry.
Table 11
Comparison of different methods on the Lung Cancer dataset.
Feature selection method None M-SVM-RFE MSVDD-RFE
C1 – 100 0.02
C2 – – 0.09
C3 – – 0.10
C4 – – 0.33
C5 – – 0.11
Recall of ADEN (%) 100.00 ± 0.00 100.00 ± 0.00 99.52 ± 0.01
Recall of SQUA (%) 46.67 ± 0.12 46.67 ± 0.05 36.67 ± 0.12
Recall of COID (%) 73.33 ± 0.15 100.00 ± 0.00 93.33 ± 0.06
Recall of SCLC (%) 0.00 ± 0.00 22.22 ± 0.19 33.33 ± 0.33
Recall of NORMAL (%) 67.17 ± 0.07 87.50 ± 0.00 87.50 ± 0.00
Average recall (%) 59.83 ± 0.02 71.28 ± 0.05 70.07 ± 0.06
Running time (s) – 31,650 8997.2
p value 0.0484 0.2653 –
Note: ‘‘none’’ means the method without feature extraction, ‘‘running time’’ means
the time consumed on feature selection, and the symbol ‘‘–’’ denotes no result in an
entry.
388 J. Cao et al. / Journal of Biomedical Informatics 53 (2015) 381–389compared methods initially, but we abandoned MSVDD-dual-
objective-RFE and MSVDD-radius-RFE for their time complexity.
The average recall and running time for the Lung Cancer dataset
are presented in Table 11. These results are similar to those for
Novartis. The average recall achieved by M-SVM-RFE, was not sig-
niﬁcantly better than for MSVDD-RFE. on the other hand, MSVDD-
RFE shows signiﬁcantly shorter computation time. Thus, again, our
proposed method is a good choice when the number of classes on a
dataset is large.
4. Conclusion
We propose a new fast gene selection method for multi-cancer
classiﬁcation using multiple SVDD models, MSVDD-RFE. This
method can efﬁciently address classiﬁcation tasks with a largenumber of features and a small number of samples. MSVDD-RFEc-
an eliminate feature redundancy and realize feature dimension
reduction simultaneously. The method also provides more com-
pact and discriminative gene subsets.
We performed experiments on ﬁve real-world datasets, Leuke-
mia, Colon Tumor, Leukemia3, Novartis and Lung Cancer. The kNN
classiﬁer and SVM are used to measure the performance of feature
selection. MSVDD-RFE provides good classiﬁcation performance
with less computation time compared to other approaches.
For the Leukemia, Colon Tumor, Leukemia3 and Novartis data-
sets, we have average recalls at better than 90%. However, the
result of the Lung Cancer dataset was unsatisfying. Since ensemble
learning can improve classiﬁcation performance, we will use
ensemble learning to provide enhanced performance on this
dataset.
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